Bruce Berkowitz's PFE Position Overview
Bruce Berkowitz (via Fairholme Capital Management LLC) currently holds 231,000 shares of Pfizer Inc. (PFE) worth $5.56 M, representing 0.37% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Bruce Berkowitz has initiated a new position in PFE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Bruce Berkowitz's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Bruce Berkowitz
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +231,000 | New Buy | 231,000 | $24.08 |
Bruce Berkowitz's Pfizer Investment FAQs
Bruce Berkowitz first purchased Pfizer Inc. (PFE) in Q2 2026, acquiring 231,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Bruce Berkowitz has held Pfizer Inc. (PFE) for 1 quarters since Q2 2026.
Bruce Berkowitz's largest addition to Pfizer Inc. (PFE) was in Q2 2026, adding 231,000 shares worth $5.56 M.
According to the latest 13F filing for Q2 2026, Bruce Berkowitz's firm, Fairholme Capital Management LLC, owns 231,000 shares of Pfizer Inc. (PFE), valued at approximately $5.56 M.
As of the Q2 2026 filing, Pfizer Inc. (PFE) represents approximately 0.37% of Bruce Berkowitz's publicly disclosed stock portfolio, making it one of their key holdings.
Bruce Berkowitz's peak holding in Pfizer Inc. (PFE) was 231,000 shares, as reported at the end of Q2 2026.